Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Anti-allergic Potential of Methanolic Extracts of Leaves and Fruit of Gmelina arborea Roxb

    wadmin1By wadmin1December 1, 2020Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Daya L Chothani1,*, NM Patel2

    1Department of Pharmacy, BK Mody Government Pharmacy College, Rajkot, Gujarat, INDIA.

    2Shri BM Shah College of Pharmaceutical Education and Research (BMCPER) Modasa, Modasa, Gujarat, INDIA.

    Pharmacognosy Communications,2020,10,4,156-160.
    DOI:10.5530/pc.2020.4.33
    Published: December 2020
    Type: Original Article

    ABSTRACT

    Objectives: An anti-allergic study was performed on a methanolic extract of leaves (GLA) and fruit (GFA) of Gmelina arborea Roxb. (Verbenaceae). Methods: Anti-allergic study was evaluated using an isolated guinea pig ileum, isolated rat ileum preparation and passive paw anaphylaxis in rats. The effect of methanolic extracts (100, 200 μg/ml) of the fruit and leaves were studied on contraction induced by histamine and acetylcholine on isolated guinea pig ileum and isolated rat ileum, respectively. The inhibition of paw volume was studied (100, 300mg/kg GLA and 100, 300mg/kgGFA, p.o.) and compared with vehicle treatment. Dexamethasone (0.27mg/kg, p.o.) was included as a positive control. Results: GLA and GFA showed significant inhibitory contraction of guinea pig ileum (p<0.01, p<0.005), rat ileum and (p< 0.01, p<0.005) rat paw volume inhibition. Conclusion: The anti-allergic activity of methanolic extracts of the fruit (GFA) and leaves (GLA) of G. arborea may be due to presence of phenolic and flavonoid compounds. The effects are noteworthy and highlight these extracts for further studies.

    Key words: Acute toxicity Gmelina arborea, Anti-allergic activity, Passive paw anaphylaxis, Phytochemical screenig.
    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up